Treatment of visual hallucinations in neurodegenerative disorders is at an early stage of development due to the underlying mechanisms being imperfectly understood. The authors consider various potential approaches to developing treatments, but caution readers that any single treatment is likely to be of limited efficacy.
Reducing medication, with the careful introduction of anti-dementia medications where appropriate, is the main method. Antipsychotics should be used only for more distressing cases and as a last resort. Education, reduction of risk factors and psychological treatments are of limited efficacy according to the evidence so far, but are less likely to cause harm.
Collerton, D. [and] Taylor. J.P. (2013). Advances in the treatment of visual hallucinations in neurodegenerative diseases. Future Neurology, July 2013, Vol.8(4), pp.433-444. (Click here to view the PubMed abstract).
[A brief reference to this item features in Dementia and Elderly Care: the Latest Evidence Newsletter (RWNHST), Volume 3 Issue 9, August 2013].